P1.11-12 Interrogation of an Exhaled MicroRNA Panel for Lung Cancer Risk Assessment

Journal of Thoracic Oncology - United States
doi 10.1016/j.jtho.2018.08.828
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

P1.11-05 Metabolomic Profiling for Second Primary Lung Cancer Among Lung Cancer Survivors

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

P1.11-15 Application of Lung-Rads vs. PAN-CAN Nodule Risk Calculation in the Alberta Lung Cancer Screening Study

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

P1.11-06 Lung Cancer Probability in New Perifissural Nodules Detected in a Lung Cancer Screening Study

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

A Panel of microRNA Signature in Serum for Colorectal Cancer Diagnosis

Oncotarget
Oncology
2017English

HPV in Exhaled Breath Condensate of Lung Cancer Patients

British Journal of Cancer
Cancer ResearchOncology
2011English

A Mathematical Model for MicroRNA in Lung Cancer

PLoS ONE
Multidisciplinary
2013English

Noninvasive Detection of Lung Cancer by Analysis of Exhaled Breath

BMC Cancer
Cancer ResearchOncologyGenetics
2009English

Epidemiological Evidence for Associations Between Variants in microRNA or Biosynthesis Genes and Lung Cancer Risk

Cancer Medicine
Cancer ResearchNuclear MedicineRadiologyImagingOncology
2020English

Assessment of a Noninvasive Exhaled Breath Test for the Diagnosis of Oesophagogastric Cancer

JAMA Oncology
Cancer ResearchOncology
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy